Tetrazolderivater og fremgangsmåder til behandling af metabolismerelaterede forstyrrelser dermed

The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions conta...

Full description

Saved in:
Bibliographic Details
Main Authors SCHRADER, THOMAS, JUNG, JAE-KYU, GHARBAOUI, TAWFIK, LIANG, RUI, SCHMIDT, DARBY, SEMPLE, GRAEME, IMBRIGLIO, JASON E, COLLETTI, STEVEN, L, SKINNER, PHILIP, J, TATA, JAMES, R, RAGHAVAN, SUBHAREKHA
Format Patent
LanguageDanish
Published 09.10.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of ±-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
AbstractList The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of ±-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
Author SKINNER, PHILIP, J
LIANG, RUI
IMBRIGLIO, JASON E
GHARBAOUI, TAWFIK
JUNG, JAE-KYU
RAGHAVAN, SUBHAREKHA
SCHMIDT, DARBY
SCHRADER, THOMAS
SEMPLE, GRAEME
COLLETTI, STEVEN, L
TATA, JAMES, R
Author_xml – fullname: SCHRADER, THOMAS
– fullname: JUNG, JAE-KYU
– fullname: GHARBAOUI, TAWFIK
– fullname: LIANG, RUI
– fullname: SCHMIDT, DARBY
– fullname: SEMPLE, GRAEME
– fullname: IMBRIGLIO, JASON E
– fullname: COLLETTI, STEVEN, L
– fullname: SKINNER, PHILIP, J
– fullname: TATA, JAMES, R
– fullname: RAGHAVAN, SUBHAREKHA
BookMark eNqNi0kKAjEURLPQhdMd4gFcSKvQawcEt9k3v00lBjI0P0HQ-3gSL2YED-CqqHr1pmIUU8REkEJheiavwe5OBSyTlYYRLEWbw_tVgSzOyx43itq7aCUZGVCoT97lAIb_etCQJnEuD65LrlY1A_RcjA3VvvjlTCxPR7U_rzCkDnmgKyJKd7ist2272bVKNc0_nw-ZhUIp
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DK1599469TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_DK1599469TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 13:14:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Danish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DK1599469TT33
Notes Application Number: DK20040818324T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061009&DB=EPODOC&CC=DK&NR=1599469T3
ParticipantIDs epo_espacenet_DK1599469TT3
PublicationCentury 2000
PublicationDate 20061009
PublicationDateYYYYMMDD 2006-10-09
PublicationDate_xml – month: 10
  year: 2006
  text: 20061009
  day: 09
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies MERCK & CO., INC
ARENA PHARMACEUTICALS, INC
RelatedCompanies_xml – name: ARENA PHARMACEUTICALS, INC
– name: MERCK & CO., INC
Score 2.6560018
Snippet The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Tetrazolderivater og fremgangsmåder til behandling af metabolismerelaterede forstyrrelser dermed
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061009&DB=EPODOC&locale=&CC=DK&NR=1599469T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dS8MwFL3MKeqbTkXnBxGkb8V266x5GML6wXDsA6myt5G26Sis7Wgjov_HX-If8yZs0xd9Kw0JTeD0npPk3AtwY1MkrSiU9ci2bd2yDK5T2jJ1ZsU8vo8wosRSKA5Hd_1n63HamdYgXXthVJ7QN5UcEREVId6F-l8vfzaxXHW3sroNU3xVPPhB19U26thEzqC5va43GbtjR3OcrjvQRk8IbEpRCQbtLdhGFm1LMHgvPWlKWf6OKP4B7ExwsFwcQi1mDdhz1oXXGrA7XJ134-MKetURsICLkn0Usqq2rEjGS1LMSVLybM7yeZV9fWIDEemCSOd9HkubOWEJyXAeYbFIq4wr34qszckJUtVKvJcymTL2wp4YFI_h2vcCp6_jt8426zJzB-tZBe32CdTzIuenQGirFfHQMmIjMS3TtMOOESVIExIUwgkz6Bk0_x6n-V_jOeyrHQh5fk4voC7KV36JMVmEV2o1vwGfdpRY
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dS8MwFL3MKc43nYrOrwjSt2K7ddY8DGHtxnSfSBXfRtqmo7C2o42I_h9_iX_Mm7BNX_StNCQ0gdN7TpJzL8CVTZG0olDWA9u2dcsyuE5p3dSZFfLwNsCIEkqhOBzd9J6sh5fmSwnilRdG5Ql9U8kREVEB4l2o__XiZxPLVXcri2s_xlfZXddrudpaHZvIGTS33epMxu7Y0Ryn5fa10SMCm1JUgl5jAzaRYdsSDJ3ntjSlLH5HlO4ubE1wsFTsQSlkVag4q8JrVdgeLs-78XEJvWIfmMdFzj4yWVVbViTjOclmJMp5MmPprEi-PrGBiHhOpPM-DaXNnLCIJDgPP5vHRcKVb0XW5uQEqWoh3nOZTBl7YU8Migdw2e14Tk_Hb52u12Xq9lez8hqNQyinWcqPgNB6PeC-ZYRGZFqmaftNI4iQJkQohCNm0GOo_T1O7b_GC6j0vOFgOrgf9U9gR-1GyLN0egplkb_yM4zPwj9XK_sNwTOXSw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Tetrazolderivater+og+fremgangsm%C3%A5der+til+behandling+af+metabolismerelaterede+forstyrrelser+dermed&rft.inventor=SCHRADER%2C+THOMAS&rft.inventor=JUNG%2C+JAE-KYU&rft.inventor=GHARBAOUI%2C+TAWFIK&rft.inventor=LIANG%2C+RUI&rft.inventor=SCHMIDT%2C+DARBY&rft.inventor=SEMPLE%2C+GRAEME&rft.inventor=IMBRIGLIO%2C+JASON+E&rft.inventor=COLLETTI%2C+STEVEN%2C+L&rft.inventor=SKINNER%2C+PHILIP%2C+J&rft.inventor=TATA%2C+JAMES%2C+R&rft.inventor=RAGHAVAN%2C+SUBHAREKHA&rft.date=2006-10-09&rft.externalDBID=T3&rft.externalDocID=DK1599469TT3